US Stock MarketDetailed Quotes
INO Inovio Pharmaceuticals
- 5.6700
- +0.0500+0.89%
Close Nov 6 16:00 ET
- 5.7000
- +0.0300+0.53%
Post 17:22 ET
147.22MMarket Cap-1118P/E (TTM)
5.8000High5.5800Low324.28KVolume5.7500Open5.6200Pre Close1.85MTurnover1.38%Turnover RatioLossP/E (Static)25.96MShares14.748052wk High1.52P/B133.14MFloat Cap4.032052wk Low--Dividend TTM23.48MShs Float2352.0000Historical High--Div YieldTTM3.92%Amplitude3.8880Historical Low5.6930Avg Price1Lot Size
About Inovio Pharmaceuticals Company
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
Company Profile
SymbolINO
Company NameInovio Pharmaceuticals
Listing DateDec 8, 1998
Founded1983
CEODr. Jacqueline E. Shea
MarketNASDAQ
Employees122
Fiscal Year Ends12-31
Address660 West Germantown Pike,Suite 110
CityPlymouth Meeting
ProvincePennsylvania
CountryUnited States of America
Zip Code19462-1111
Phone1-267-440-4200
Websitehttp://www.inovio.com
Company Executives
-
Name
- Position
- Salary
-
Dr. Jacqueline E. Shea
- President, Chief Executive Officer and Director
- 2.07M
-
Dr. Laurent Humeau, PhD
- Chief Scientific Officer
- 976.66K
-
Michael John Sumner
- Chief Medical Officer
- --
-
Peter D. Kies
- Chief Financial Officer and Principal Accounting Officer
- 988.73K
-
Simon X. Benito
- Chairman of the Board
- 151.19K
-
Dr. David B. Weiner, PhD
- Director
- 201.79K
-
Wendy L. Yarno, M.B.A.
- Independent Director
- 123.69K
-
Dr. Roger D. Dansey, M.D.
- Independent Director
- 108.69K
-
Jay P. Shepard
- Independent Director
- 119.31K
-
Lota S. Zoth, C.P.A.
- Independent Director
- 118.69K
-
Dr. Ann C. Miller, M.D.
- Independent Director
- 126.94K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
